Immuneering Corporation IMRX
Set alert
3.68 USD +0.18 +5.30%
As of Nov 3, 1:42 PM ET
3.52 Day range 3.74
3.38 52-week range 8.48
- YTD
- -44.15%
- 1 year
- -43.98%
- Open
- 3.52
- Prev close
- 3.49
- Mkt cap
- 238.00M
- Vol
- 409.93K
- Avg vol
- 718.86K
- EPS
- -0.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.52
- High
- 3.74
- Forward P/E
- -1.34
- Beta
- -0.40
- Short ratio
- 1.19
- Inst. own
- 30.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 2.01
- 200-d avg
- 1.84
- 1y target
- 12.42
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 13, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
Held by funds
44 US ETFs and mutual funds hold IMRX · largest positions
Ownership
Held by insiders 29.12%
Held by institutions 30.11%
Float held by institutions 42.48%
Institutions 65
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.45% | 1,070,322 | 2.35M | Sep 29, 2024 |
| Price (T.Rowe) Associates Inc | 2.61% | 810,127 | 1.78M | Sep 29, 2024 |
| Morgan Stanley | 1.45% | 449,311 | 988.48K | Sep 29, 2024 |
| Blackrock Inc. | 1.03% | 318,419 | 700.52K | Sep 29, 2024 |
| Millennium Management Llc | 0.79% | 246,270 | 541.79K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.68% | 209,641 | 461.21K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.37% | 736,188 | 1.62M | Sep 29, 2024 |
| Price (T.Rowe) Health Sciences Fund | 1.64% | 509,134 | 1.12M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.93% | 289,196 | 636.23K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.38% | 118,328 | 260.32K | Oct 30, 2024 |
| ETF Series Solutions-Range Cancer Therapeutics ETF | 0.21% | 64,035 | 140.88K | Aug 30, 2024 |
| iShares Micro Cap ETF | 0.16% | 49,849 | 109.67K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERMAN ANN E | Director | Purchase | Mar 17, 2024 | 67,465 |
| BOOKMAN MICHAEL | Officer | Stock Award(Grant) | Mar 14, 2024 | 3,850 |
| BRAKEWOOD HAROLD EUGENE | Officer | Purchase | Mar 21, 2024 | 3,900 |
| CORMORANT ASSET MANAGEMENT ,L.P | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 31, 2024 | 0 |
| FEINBERG PETER | Director | Purchase | Mar 21, 2024 | 1,096,060 |
| HALL BRETT MATTHEW | Officer | Purchase | Mar 19, 2024 | 345,896 |
